Réka Faludi, Máté Hajdu, Vivien Vértes, Ágnes Nógrádi, Noémi Varga, Miklós Balázs Illés, Veronika Sárosi, György Alexy, András Komócsi,
Right ventricular (RV) systolic failure is rare in patients with COPD, but they often develop RV diastolic dysfunction. Left ventricular (LV) diastolic dysfunction is also common in this population. Nevertheless, data are scarce regarding the effect of diastolic dysfunction on the functional capacity in patients with COPD. We investigated the correlation between echocardiographic parameters of RV and LV diastolic function and the exercise capacity in COPD, by using conventional echocardiographic methods ...
Tópico(s): Chronic Obstructive Pulmonary Disease (COPD) Research
2015 - Informa | COPD Journal of Chronic Obstructive Pulmonary Disease
Veronika Sárosi, György Losonczy, E. Francovszky, Edina Tolnay, Szilvia Török, Gabriella Gálffy, Balázs Hegedűs, Balázs Döme, Gyula Ostoros,
Erlotinib is an epidermal growth factor receptor tyrosine-kinase inhibitor (EGFR-TKI), used for the treatment of non-small cell lung cancer. As the clinical significance of KRAS mutational status has not yet been clearly determined in this setting, our aim was to investigate the efficacy of erlotinib in advanced KRAS mutation-negative lung adenocarcinoma patients.MOTIVATE is an open-label, multicenter, observational trial with Tarceva(®) (erlotinib) monotherapy. Enrolled patients with advanced (stage ...
Tópico(s): Lung Cancer Diagnosis and Treatment
2014 - Elsevier BV | Lung Cancer
Lilla Tamási, Krisztián Horváth, Zoltán Kiss, Krisztina Bogos, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zoltán Polányi, Zsófia Nagy-Erdei, Andrea R. Daniel, Balázs Nagy, György Rokszin, Zsolt Abonyi‐Tóth, Judit Moldvay, Zoltán Vokó, Gabriella Gálffy,
Objective: No assessment was conducted describing the age and gender specific epidemiology of lung cancer (LC) prior to 2018 in Hungary, thus the objective of this study was to appraise the detailed epidemiology of lung cancer (ICD-10 C34) in Hungary based on a retrospective analysis of the National Health Insurance Fund database. Methods: This longitudinal study included patients aged ≥20 years with LC diagnosis (ICD-10 C34) between January 1, 2011 and December 31, 2016. Patients with different cancer- ...
Tópico(s): Global Cancer Incidence and Screening
2021 - Springer Science+Business Media | Pathology & Oncology Research
Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zoltán Polányi, Zsófia Nagy-Erdei, Zoltán Vokó, Balázs Nagy, Krisztián Horváth, György Rokszin, Zsolt Abonyi‐Tóth, Judit Moldvay,
Objective: While Hungary is often reported to have the highest incidence and mortality rates of lung cancer, until 2018 no nationwide epidemiology study was conducted to confirm these figures. The objective of this study was to estimate the occurrence of lung cancer in Hungary based on a retrospective review of the National Health Insurance Fund (NHIF) database. Methods: Our retrospective, longitudinal study included patients aged ≥20 years who were diagnosed with lung cancer (ICD-10 C34) between 1 ...
Tópico(s): Multiple and Secondary Primary Cancers
2019 - Frontiers Media | Frontiers in Oncology
Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zoltán Polányi, Zsófia Nagy-Erdei, Zoltán Vokó, Balázs Nagy, Krisztián Horváth, György Rokszin, Zsolt Abonyi‐Tóth, Zsófia Barcza, Judit Moldvay,
Lung cancer is still a leading cause of cancer-related death in Hungary. On the basis of the mortality trends of previous years in which there is a decreasing incidence of lung cancer in males but an increasing incidence in females, no significant change can be expected in overall numbers6Bogos K. Kiss Z. Gálffy G. et al.Revising incidence and mortality of lung cancer in Central Europe: an epidemiology review from Hungary.Front Oncol. 2019; 9: 1051Crossref PubMed Scopus (24) Google Scholar and Hungary ...
Tópico(s): Global Cancer Incidence and Screening
2020 - Elsevier BV | Journal of Thoracic Oncology
Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Олександр Войтко, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Każarnowicz, György Losonczy, Nikolay Conev, J. Armstrong, Natalie Byrne, Norah J. Shire, Haiyi Jiang, Jonathan W. Goldman, Emilio Batagelj, Ignacio Casarini, Anea Viviana Pastor, S. Sena, Juan José Zarbá, Otto C. Burghuber, Sylvia Hartl, Maximilian J. Hochmair, Bernd Lamprecht, Michael Studnicka, Luís Alberto Schlittler, Fabrício Augusto Martinelli de Oliveira, Aknar Calabrich, Gustavo Girotto, Peo Dos Reis, Carlos Fausto Nino Gorini, Peo Rafael Martins De Marchi, Clarissa Baldotto, Cláudia Vaz de Melo Sette, Mauro Zukin, Nikolay Conev, Assen Dudov, Rumyana Ilieva, Krassimir Koynov, Rositsa Krasteva, Ivan Tonev, Spartak Valev, Violetka Venkova, Minghong Bi, Chengshui Chen, Yuan Chen, Zhendong Chen, Jian Fang, Jifeng Feng, Zhigang Han, Jie Hu, Yi Hu, Xing Li, Zongan Liang, Lin Zhong, Rui Ma, Shenglin Ma, Kejun Nan, Yongqian Shu, Kai Wang, Mengzhao Wang, Gang Wu, Nong Yang, Zhixiong Yang, Helong Zhang, Wei Zhang, Jun Zhao, Yanqiu Zhao, Caicun Zhou, Jianying Zhou, Xiangdong Zhou, Libor Havel, Vı́tězslav Kolek, Leona Koubková, Jaromı́r Roubec, Jana Skřičková, Milada Zemanová, C. Chouaïd, Werner Hilgers, H. Léna, Denis Moro‐Sibilot, G. Robinet, Pierre-Jean Souquet, Jürgen Alt, Helge Bischoff, Christian Grohé, Eckart Laack, Susanne Lang, Jens Panse, Niels Reinmuth, Christian Schulz, Krisztina Bogos, Eszter Csánky, Anea Fülöp, Zsolt Horváth, Judit Kósa, Ibolya Laczó, György Losonczy, Gábor Pajkos, Zsuzsanna Pápai, Zsolt Pápai Székely, Veronika Sárosi, A Somfay, Éva Somogyiné Ezer, Anás Telekes, Jair Bar, Maya Gottfried, Norman Heching, Alona Zer, Roberta Bartolucci, Anna Bettini, Angelo Delmonte, Marina Chiara Garassino, Mauro Minelli, Fausto Roila, Francesco Verderame, Shinji Atagi, Koichi Azuma, Hisatsugu Goto, Kōichi Goto, Yu Hara, Hidetoshi Hayashi, Toyoaki Hida, Katsuyuki Hotta, Kenya Kanazawa, Shintaro Kanda, Young Hak Kim, Shoichi Kuyama, Tadashi Maeda, Masahiro Morise, Yasuharu Nakahara, Makoto Nishio, Naoyuki Nogami, Isamu Okamoto, Haruhiro Saito, Masahiro Shinoda, Shigeki Umemura, Tatsuya Yoshida, Niels Claessens, Robin Cornelissen, Lizza Heniks, J.T.J.N. Hiltermann, Egbert F. Smit, Agnes Staal van den Brekel, Andrzej Każarnowicz, Dariusz M. Kowalski, Sławomir Mańdziuk, Robert Mróz, Marek Z. Wojtukiewicz, Tudor‐Eliade Ciuleanu, Doina Ganea, Anei Ungureanu, Mikhail Dvorkin, Alexander Luft, В. Моисеенко, Artem Poltoratskiy, Dina Sakaeva, Alexey Smolin, Galina Statsenko, Alexander Vasilyev, Lyubov Vladimirova, Igor Anasina, Jozef Chovanec, Pavol Demo, Robert Godal, Peter Kasan, Marian Streško, M. Urda, Eun Kyung Cho, Jun Ho Ji, Joo-Hang Kim, Sang‐We Kim, Gyeong‐Won Lee, Jong-Seok Lee, Ki Hyeong Lee, Kyung Hee Lee, Yun Gyoo Lee, Amelia Insa, M. Dómine Gómez, Juan Ignacio Delgado Mingorance, D. Casado, Marta López Brea, M. Majem Tarruella, Teresa Morán Bueno, Alejano Navarro Mendivil, Luis Paz-Ares Rodríguez, Santiago Ponce Aix, M.R. García Campelo, Gee‐Chen Chang, Yen‐Hsun Chen, Chao‐Hua Chiu, Te‐Chun Hsia, Kang‐Yun Lee, Chien-Te Li, Chin‐Chou Wang, Yufeng Wei, Shang‐Yin Wu, Ahmet Alacacıoğlu, İrfan Çiçin, Ahmet Demirkazık, Mustafa Erman, Tuncay Göksel, Mustafa Özgüroğlu, Hryhoriy Adamchuk, Igor Bondarenko, Oleksii Kolesnik, Anna Kryzhanivska, Yuriv Ostapenko, Serhii Shevnia, Yaroslav Shparyk, Dmytro Trukhin, Grygorii Ursol, Олександр Войтко, Олександр Войтко, Ihor Vynnychenko, Sunil Babu, Yuanbin Chen, Anne C. Chiang, Winston Chua, Shaker R. Dakhil, Afshin Dowlati, Jonathan W. Goldman, Basir Haque, Rodney Jamil, Jeanna Knoble, Shailena Lakhanpal, Kailhong Mi, Petros Nikolinakos, Steven Powell, Helen J. Ross, Eric Schaefer, Jeffrey Schneider, Joseph E. Spahr, David R. Spigel, Joseph Stilwill, Christopher Sumey, Michael Williamson,
Most patients with small-cell lung cancer (SCLC) have extensive-stage disease at presentation, and prognosis remains poor. Recently, immunotherapy has demonstrated clinical activity in extensive-stage SCLC (ES-SCLC). The CASPIAN trial assessed durvalumab, with or without tremelimumab, in combination with etoposide plus either cisplatin or carboplatin (platinum-etoposide) in treatment-naive patients with ES-SCLC.This randomised, open-label, phase 3 trial was done at 209 sites across 23 countries. Eligible ...
Tópico(s): Peptidase Inhibition and Analysis
2019 - Elsevier BV | The Lancet
Xénia Gonda, Konstantinos Ν. Fountoulakis, Gábor Csukly, György Bagdy, Dorottya Pap, Eszter Molnár, András Lászik, Judit Lazáry, Andrea Sárosi, Gábor Faludi, Mária Sasvári‐Székely, Anna Székely, Zoltán Rihmer,
The 5-HTTLPR polymorphism has been associated both with depression and aggression/hostility. The multidirectional association between depression, aggression and the s allele may be important, since all these phenomena are related to suicidal behavior. Our aim was to investigate the association between 5-HTTLPR and aggressive/hostile traits in depressed patients and controls. 137 depressive and 118 control women completed the Buss–Durkee Hostility Inventory and were genotyped for 5-HTTLPR. BDHI scores ...
Tópico(s): Tryptophan and brain disorders
2011 - Elsevier BV | Journal of Affective Disorders
Krisztina Bogos, Zoltán Kiss, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zoltán Polányi, Zsófia Nagy-Erdei, Andrea R. Daniel, Zoltán Vokó, Balázs Nagy, Krisztián Horváth, György Rokszin, Zsolt Abonyi‐Tóth, Zsófia Barcza, Gabriella Gálffy, Judit Moldvay,
Objective: Lung cancer is one of the most common cancers worldwide and its survival is still poor. The objective of our study was to estimate long-term survival of Hungarian lung cancer patients at first time based on a nationwide review of the National Health Insurance Fund database. Methods: Our retrospective, longitudinal study included patients aged ≥20 years who were diagnosed with lung cancer (ICD-10 C34) between January 1, 2011 and December 31, 2016. Survival rates were evaluated by year of ...
Tópico(s): Lung Cancer Diagnosis and Treatment
2021 - Springer Science+Business Media | Pathology & Oncology Research
Flavio D’Ascenzi, Matteo Cameli, Marco Lisi, Marta Focardi, Valentina Andrei, Eufemia Incampo, Marco Bonifazi, Sergio Mondillo, Monika Przewłocka‐Kosmala, Agnieszka Rojek, Andrzej Mysiak, Wojciech Kosmala, Sebastian Spethmann, Henryk Dreger, R.E. Meyn, Enkhtuyaa Mueller, G. Baumann, M. Quinkler, Fabian Knebel, O. Enescu, Roxana Cristina Rimbaş, Mircea Cinteză, Dragoş Vinereanu, Karima Addetia, Francesco Maffessanti, Megan Yamat, Lynn Weinert, Victor Mor‐Avi, Richard Lang, Réka Faludi, N. Varga-Nagy, Victor Vertes, Máté Hajdu, Miklós Balázs Illés, Veronika Sárosi, György Alexy, E. Hamodraka, Nestoras Kontogiannis, Manolis S. Kallistratos, I. Zacharopoulou, T. Zamfir, Christos Manetos, Katerina Siama, A. Tsoukas, A. Skyrlas, Antonis S. Manolis, Daniel Fuertes, Manuel Crespín Crespín, E. Villanueva Fernandez, Lucia Krisdinarti, Lidwina br Tarigan, Hasanah Mumpuni, Dyah Wulan Anggrahini, Alexander Van De Bruaene, André La Gerche, Guido Claessen, Pieter De Meester, Sarah Devroe, J. Bogaert, Piet Claus, Hein Heidbüchel, Marc Gewillig, Werner Budts,
Tópico(s): Sports injuries and prevention
2014 - Oxford University Press | European Heart Journal - Cardiovascular Imaging
Gyula Ostoros, Veronika Sárosi, György Losonczy, János Strausz, Edina Tolnay, László Molnár,
histology, stage of disease, presence of BM, survial were collected and analyzed.A multivariate logistic regression model was used to identiy the predictors of BM.Results: Among 596 NSCLC patients with a mean follow-up time of 12.5± 12.5 months and a mortality rate of 62% at the last follow up, 187 (31%) experienced BM during their disease course.The accumulative incidence of BM was higher in patients with adenocarcinoma (ADC) than those with squamous cell carcinoma (SCC) (36% vs 13%, p < 0.001).On multivatiate ...
Tópico(s): Peptidase Inhibition and Analysis
2012 - Elsevier BV | Annals of Oncology
Gyula Ostoros, Veronika Sárosi, György Losonczy, Edina Tolnay, László Molnár,
As many breast cancer patients receive adjuvant chemotherapy using anthracyclines or anthracenediones and taxanes, more therapeutic options are needed for subsequent lines of therapy. Pemetrexed (ALIMTA®, multitargeted antifolate, LY231514) is a novel antifolate that inhibits several enzymes in the de novo pathways of pyrimidine and purine biosynthesis. This paper reports on a subset analysis of a phase II clinical trial of pemetrexed in heavily pretreated metastatic breast cancer (MBC) patients. ...
Tópico(s): Cancer therapeutics and mechanisms
2009 - Elsevier BV | European Journal of Cancer Supplements
Judit Frigyesi, Bálint Sárosi, György Martin, János Manga,
Tópico(s): Folklore, Mythology, and Literature Studies
1991 - University of Illinois Press | Ethnomusicology
Josef Lansky, Wolfgang Suppan, Pál Járdányi, Mate Pal, Imre Olsvai, Hona Racz, Baliut Sarosi, György Kerényi,
Tópico(s): Eurasian Exchange Networks
1966 - De Gruyter | Jahrbuch für Volksliedforschung
Many researchers have investigated different properties and behaviour of pneumatic muscles actuators (PMAs). Most of them have dealt with the force-contraction (force-relative displacement) characteristics or control of PMAs. In this paper two different type PMAs are compared: Fluidic Muscle made by Festo Company and Shadow Air Muscle made by Shadow Robot Company. The most relevant difference between them can be noticed in their structure. The Fluidic Muscle is an embedded muscle which means the load ...
Tópico(s): Muscle activation and electromyography studies
2015 - University of Szeged | Analecta Technica Szegedinensia
... collecting data on folk dances and folk music. Gyorgy Martin and Balint Sarosi studied different Ethiopian dances by comparing them with ...
Tópico(s): Diversity and Impact of Dance
2005 - Japan Society of Physical Education, Health and Sport Sciences | Taiikugaku kenkyu (Japan Journal of Physical Education Health and Sport Sciences)
Tamás Erdélyi, Anikó Bohács, Krisztina Vincze, Zsuzsanna Kováts, Veronika Sárosi, András Sinkovicz, György Balázs, Veronika Müller,
Lymphangioleiomyomatosis (LAM) is a rare disease that affects women, especially in child-bearing age. Clinical manifestations include angiomyolipoma, pneumothorax, chylothorax, cystic changes of lungs and progressive pulmonary failure. In this article, we report a case of lung transplantation (LuTX) for end stage pulmonary LAM and the treatment of angiomyolipoma showing growth after LuTX resulting in complete remission with combination therapy of everolimus and tacrolimus.
Tópico(s): Eosinophilic Disorders and Syndromes
2014 - Scientific Research Publishing | Case Reports in Clinical Medicine
Zoltán Kiss, Gabriella Gálffy, Veronika Müller, Judit Moldvay, Veronika Sárosi, Zsolt Pápai-Székely, Edit Csada, Anna Kerpel-Fronius, Zsolt Király, Zoltán Szász, Gábor Hódi, Zoltán Polányi, Krisztina Kovács, Eugenia Karamousouli, Kata Knollmajer, Tamás Szabó, Andrea Berta, Zoltán Vokó, György Rokszin, Zsolt Abonyi‐Tóth, Zsófia Barcza, Lilla Tamási, Krisztina Bogos,
The approval of immunotherapy (I-O) for the treatment of late-stage non-small cell lung cancer (NSCLC) opened new perspectives in improving survival outcomes. However, survival data have not yet been provided from the period of the Covid-19 pandemic. The aims of our study were to assess and compare survival outcomes of patients with advanced LC receiving systemic anticancer treatment (SACT) before and after the approval of immunotherapy in Hungary, and to examine the impact of pandemic on survival ...
Tópico(s): Lung Cancer Treatments and Mutations
2023 - Frontiers Media | Frontiers in Oncology
Gabriella Gálffy, Aladár Vastag, Krisztina Bogos, Zoltán Kiss, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Zoltán Polányi, Zsófia Nagy-Erdei, Andrea R. Daniel, Kata Knollmajer, Máté Várnai, Péter Szegner, Zoltán Vokó, Balázs Nagy, Krisztián Horváth, György Rokszin, Zsolt Abonyi‐Tóth, Éva Pozsgai, Zsófia Barcza, Judit Moldvay, Lilla Tamási,
Objective: Hungary has one of the highest incidences and mortality rates of lung cancer (LC), therefore the objective of this study was to analyse and compare LC incidence and mortality rates between the main Hungarian regions. Methods: This nationwide, retrospective study used data from the National Health Insurance Fund and included patients aged ≥20 years who were diagnosed with lung cancer (ICD-10 C34) between Jan 1, 2011 and Dec 31, 2016. Age-standardized incidence and mortality rates were calculated ...
Tópico(s): Multiple and Secondary Primary Cancers
2021 - Springer Science+Business Media | Pathology & Oncology Research
Zoltán Kiss, Krisztina Bogos, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zoltán Polányi, Zsófia Nagy-Erdei, Kata Knollmajer, Máté Várnai, Balázs Nagy, Krisztián Horváth, György Rokszin, Zsolt Abonyi‐Tóth, Zsófia Barcza, Judit Moldvay, Gabriella Gálffy, Zoltán Vokó,
Objective: This study aimed to examine the characteristics of the lung cancer (LC) patient pathway in Hungary during a 6-years period. Methods: This nationwide, retrospective study included patients newly diagnosed with LC (ICD-10 C34) between January 1, 2011, and December 31, 2016, using data from the National Health Insurance Fund (NHIF) of Hungary. The following patient pathway intervals were examined: system, diagnostic and treatment interval by age, gender, tumor type, study year and first-line ...
Tópico(s): Gastric Cancer Management and Outcomes
2021 - Springer Science+Business Media | Pathology & Oncology Research
Edina Tolnay, Veronika Sárosi, Erzsébet Juhász, Zsuzsanna Sztancsik, György Losonczy, Gyula Ostoros, László Mándoky,
e19123 Background: Results of two phase III, and two phase IV trials have shown that first-line bevacizumab (BEV) in combination with chemotherapy improves clinical outcomes in patients with advanced NSCLC. The AVALANCHE (ML21783) study was undertaken to assess the clinical outcomes of first-line BEV combined with standard platinum-based regimens in the Hungarian clinical practice. Methods: This observational study was conducted in 28 Hungarian sites. Enrolment: July 2008-April 2011. Patients with ...
Tópico(s): Hepatocellular Carcinoma Treatment and Prognosis
2014 - Lippincott Williams & Wilkins | Journal of Clinical Oncology
Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Marina Chiara Garassino, Олександр Войтко, Artem Poltoratskiy, Santiago Ponce, Francesco Verderame, Libor Havel, Igor Bondarenko, Andrzej Każarnowicz, György Losonczy, Nikolay Conev, J. Armstrong, Natalie Byrne, Piruntha Thiyagarajah, Haiyi Jiang, Luis Paz‐Ares, Mikhail Dvorkin, Dmytro Trukhin, Galina Statsenko, Олександр Войтко, Artem Poltoratskiy, Igor Bondarenko, Yuanbin Chen, Andrzej Każarnowicz, Luis Paz‐Ares, Mustafa Özgüroğlu, Nikolay Conev, Maximilian J. Hochmair, Otto C. Burghuber, Libor Havel, İrfan Çiçin, György Losonczy, В. Моисеенко, Mustafa Erman, Dariusz M. Kowalski, Marek Z. Wojtukiewicz, Hryhoriy Adamchuk, Alexander Vasilyev, Serhii Shevnia, Spartak Valev, Niels Reinmuth, Jun Ho Ji, Amelia Insa, Grygorii Ursol, Anne C. Chiang, Sylvia Hartl, Zsolt Horváth, Gábor Pajkos, Francesco Verderame, Katsuyuki Hotta, Sang‐We Kim, Alexey Smolin, Tuncay Göksel, Shaker R. Dakhil, Jaromı́r Roubec, Krisztina Bogos, Marina Chiara Garassino, Robin Cornelissen, Jong-Seok Lee, M.R. García Campelo, Marta López Brea, Ahmet Alacacıoğlu, Ignacio Casarini, Rumyana Ilieva, Ivan Tonev, A Somfay, Jair Bar, Alona Zer, Mauro Minelli, Roberta Bartolucci, Fausto Roila, Haruhiro Saito, Koichi Azuma, Gyeong‐Won Lee, Alexander Luft, M. Urda, Juan Ignacio Delgado Mingorance, M. Majem Tarruella, David R. Spigel, Krassimir Koynov, Milada Zemanová, Jens Panse, Christian Schulz, Zsolt Pápai Székely, Veronika Sárosi, Angelo Delmonte, Anna Bettini, Makoto Nishio, Isamu Okamoto, Lizza Hendriks, Sławomir Mańdziuk, Yun Gyoo Lee, Lyubov Vladimirova, D. Casado, M. Dómine Gómez, Alejandro Navarro, Teresa Morán Bueno, Shang‐Yin Wu, Jeanna Knoble, Jana Skřičková, Violetka Venkova, Werner Hilgers, Eckart Laack, Helge Bischoff, Andrea Fülöp, Ibolya Laczó, Judit Kósa, András Telekes, Tatsuya Yoshida, Shintaro Kanda, Toyoaki Hida, Hidetoshi Hayashi, Tadashi Maeda, Tetsuji Kawamura, Yasuharu Nakahara, Niels Claessens, Ki Hyeong Lee, Chao‐Hua Chiu, Sheng‐Hao Lin, Chien-Te Li, Ahmet Demirkazık, Eric Schaefer, Petros Nikolinakos, Jeffrey Schneider, Sunil Babu, Bernd Lamprecht, Michael Studnicka, Carlos Fausto Nino Gorini, Juraj Kultan, Vı́tězslav Kolek, Pierre-Jean Souquet, Denis Moro‐Sibilot, Maya Gottfried, Egbert F. Smit, Kyung Hee Lee, Peter Kasan, Jozef Chovanec, O. Goloborodko, Oleksii Kolesnik, Yuriy Ostapenko, Shailendra Lakhanpal, Basir Haque, Winston Chua, Joseph Stilwill, S. Sena, Gustavo Girotto, Pedro Rafael Martins De Marchi, Fabrício Augusto Martinelli de Oliveira, Pedro Dos Reis, Rositsa Krasteva, Yanqiu Zhao, Chengshui Chen, Leona Koubková, G. Robinet, C. Chouaïd, Christian Grohé, Jürgen Alt, Eszter Csánky, Éva Somogyiné Ezer, Norman Heching, Young Hak Kim, Shinji Aatagi, Shoichi Kuyama, Daijiro Harada, Naoyuki Nogami, Hiroshi Nokihara, Hisatsugu Goto, Agnes Staal van den Brekel, Eun Kyung Cho, Joo-Hang Kim, Doina Ganea, Tudor‐Eliade Ciuleanu, Ekaterine Popova, Dina Sakaeva, Marian Streško, Pavol Demo, Robert Godal, Yufeng Wei, Yen‐Hsun Chen, Te‐Chun Hsia, Kang‐Yun Lee, Huang‐Chih Chang, Chin‐Chou Wang, Afshin Dowlati, Christopher Sumey, Steven Powell, Jonathan W. Goldman, Juan José Zarbá, Emilio Batagelj, Andrea Viviana Pastor, Mauro Zukin, Clarissa Baldotto, Luís Alberto Schlittler, Aknar Calabrich, Cláudia Vaz de Melo Sette, A. P. Dudov, Caicun Zhou, H. Léna, Susanne Lang, Zsuzsanna Pápai, Kōichi Goto, Shigeki Umemura, Kenya Kanazawa, Yu Hara, Masahiro Shinoda, Masahiro Morise, J.T.J.N. Hiltermann, Robert Mróz, Andrei Ungureanu, Igor Andrašina, Gee‐Chen Chang, Ihor Vynnychenko, Yaroslav Shparyk, Anna Kryzhanivska, Helen J. Ross, Kailhong Mi, Rodney Jamil, Michael Williamson, Joseph E. Spahr, Zhigang Han, Mengzhao Wang, Zhixiong Yang, Jie Hu, Wei Li, Jun Zhao, Jifeng Feng, Shenglin Ma, Xiangdong Zhou, Zongan Liang, Yi Hu, Yuan Chen, Minghong Bi, Yongqian Shu, Kejun Nan, Jianying Zhou, Wei Zhang, Rui Ma, Nong Yang, Lin Zhong, Gang Wu, Jian Fang, Helong Zhang, Kai Wang, Zhendong Chen,
Summary Background First-line durvalumab plus etoposide with either cisplatin or carboplatin (platinum–etoposide) showed a significant improvement in overall survival versus platinum–etoposide alone in patients with extensive-stage small-cell lung cancer (ES-SCLC) in the CASPIAN study. Here we report updated results, including the primary analysis for overall survival with durvalumab plus tremelimumab plus platinum–etoposide versus platinum–etoposide alone. Methods CASPIAN is an ongoing, open-label, sponsor- ...
Tópico(s): Neuroendocrine Tumor Research Advances
2020 - Elsevier BV | The Lancet Oncology
Sándor Csikós, György Czifra, József Sárosi,
Industry 4.0 requires the cooperation of several technologies. The intersections of these technologies present us with new challenges. One of these challenges is identification, since we have to identify all the items that are on the network that do work and those that are worked upon. If we fail to identify one of these items the network is presented with an unidentified potentially malicious device or a misidentified product which can cause production to halt. Blockchains or otherwise known as ...
Tópico(s): IoT and Edge/Fog Computing
2021 - University of Szeged | Analecta Technica Szegedinensia
Zolta ́n Kiss, Krisztina Bogos, Lilla Tamási, Gyula Ostoros, Veronika Müller, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Kata Knollmajer, Máté Várnai, Krisztina Kovács, Andrea Berta, István Köveskuti, Eugenia Karamousouli, György Rokszin, Zsolt Abonyi‐Tóth, Zsófia Barcza, István Kenessey, András Wéber, Péter Nagy, Petra Fadgyas‐Freyler, Miklós Szócska, Péter Szegner, Lászlóné Hilbert, Gabriella Branyiczkiné Géczy, György Surján, Judit Moldvay, Zoltán Vokó, Gabriella Gálffy, Zoltán Polányi,
Objective The Hungarian Undiagnosed Lung Cancer (HULC) study aimed to explore the potential reasons for missed LC (lung cancer) diagnosis by comparing healthcare and socio-economic data among patients with post-mortem diagnosed LC with those who were diagnosed with LC during their lives. Methods This nationwide, retrospective study used the databases of the Hungarian Central Statistical Office (HCSO) and National Health Insurance Fund (NHIF) to identify patients who died between January 1, 2019 and ...
Tópico(s): Lung Cancer Treatments and Mutations
2022 - Frontiers Media | Frontiers in Oncology
Krisztina Bogos, Zoltán Kiss, Lilla Tamási, Gyula Ostoros, Veronika Judit Dr Szabone Dr Muller, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zsófia Nagy-Erdei, Zoltán Polányi, Andrea R. Daniel, Balázs Nagy, Krisztián Horváth, Zsolt Abonyi‐Tóth, György Rokszin, Zoltán Vokó, Judit Moldvay,
e21582 Background: Lung cancer is one of the most common cancers worldwide, however, 5-year survival is poor, only 10-20% of pataients survive this period. To date, no long-term study has been conducted to evaluate long-term survival rates in Hungary. Therefore, the objective of our study was to assess the 6-year survival of lung cancer patients (ICD-10 C34) based on a nationwide review of the National Health Insurance Fund (NHIF) database. Methods: Our retrospective, longitudinal study included patients ...
Tópico(s): Multiple and Secondary Primary Cancers
2020 - Lippincott Williams & Wilkins | Journal of Clinical Oncology
Krisztina Bogos, G. Gaffly, Zoltán Kiss, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zoltán Polányi, Andrea R. Daniel, Balázs Nagy, György Rokszin, Zsolt Abonyi‐Tóth, Zsófia Barcza, Judit Moldvay, Zoltán Vokó,
Background: This study aimed to examine the characteristics of the lung cancer (LC) patient pathway in Hungary during a 6-year period. Methods: Methods This nationwide, retrospective study included patients newly diagnosed with LC (ICD-10 C34) between January 1, 2011 and December 31, 2016 using data from the National Health Insurance Fund (NHIF) of Hungary. Following patient pathway intervals were examined: system-, diagnostic- and treatment interval by age, gender, tumor type, study year and first- ...
Tópico(s): Multiple and Secondary Primary Cancers
2021 - Elsevier BV | Journal of Thoracic Oncology
Tobias Peikert, Krisztina Bogos, Zoltán Kiss, Gabriella Gálffy, Lilla Tamási, Gyula Ostoros, Veronika Müller, László Urbán, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Zoltán Polányi, Zsófia Nagy-Erdei, Zoltán Vokó, Balázs Nagy, Krisztián Horváth, György Rokszin, Zsolt Abonyi‐Tóth, Zsófia Barcza, Judit Moldvay, Sufang Tian, Weidong Hu, Li Niu, Huan Liu, Xu Hai-Bo, Shu-Yuan Xiao, Graham Warren, Anthony J. Alberg, K. Michael Cummings, Carolyn Dresler, William D. Travis, Sanja Đačić, Ignacio I. Wistuba, Lynette M. Sholl, Prasad S. Adusumilli, Lukas Bubendorf, Paul A. Bunn, Tina Cascone, Jamie E. Chaft, Gang Chen, Teh‐Ying Chou, Wendy A. Cooper, Jeremy Erasmus, Carlos Gil Ferreira, Jin-Mo Goo, John V. Heymach, Fred R. Hirsch, Hidehito Horinouchi, Keith M. Kerr, Mark G. Kris, Deepali Jain, Young Kim, Fernando López‐Ríos, Shun Lu, Philippe Jamme, Marie Fernandes, Marie‐Christine Copin, Clotilde Descarpentries, Fabienne Escande, Angela Morabito, V. Grégoire, Matthieu Jamme, Simon Baldacci, David Tulasne, Zoulika Kherrouche, Alexis B. Cortot,
2020 - Elsevier BV | Journal of Thoracic Oncology
Gabriella Gálffy, Zoltán Kiss, Krisztina Bogos, Judit Moldvay, Nóra Bittner, Aladár Vastag, Zsófia Nagy-Erdei, György Rokszin, Gyula Ostoros, Veronika Judit Dr Szabone Dr Muller, Veronika Sárosi, Zoltán Polányi, Balázs Nagy, Krisztián Horváth, Zsolt Abonyi‐Tóth, Zoltán Vokó, Lilla Tamási,
e21572 Background: No assessment was conducted describing the age and gender specific epidemiology of lung cancer (LC) prior to 2018 in Hungary, thus the objective of this study was to appraise the detailed epidemiology of lung cancer (ICD-10 C34) in Hungary based on a retrospective analysis of the National Health Insurance Fund database. Methods: This longitudinal study included patients aged ≥20 years with LC diagnosis (ICD-10 C34) between 1 st January 2011 and 31 th December 2016. Patients with different ...
Tópico(s): Multiple and Secondary Primary Cancers
2020 - Lippincott Williams & Wilkins | Journal of Clinical Oncology
... fiddle at all, but rather, as ethnomusicologist Bálint Sárosi taught us a long time ago, a children’ ... Wolfgang Marx probes “The Concept of Death in György Ligeti’s Oeuvre” in the Requiem and the ...
Tópico(s): Hungarian Social, Economic and Educational Studies
2013 - Music Library Association | Notes
Gabriella Gálffy, Tamás Szabó, Lilla Tamási, Veronika Müller, Judit Moldvay, Veronika Sárosi, Anna Kerpel-Fronius, Tamás Kardos, Edit Csada, Zsolt Pápai-Székely, Zoltán Szász, Zsolt Király, Gábor Hódi, Zsuzsanna Kovács, Éva Balogh, Krisztina Kovács, Miklós Darida, Viktória Buga, György Rokszin, Zsolt Abonyi‐Tóth, Zoltán Kiss, Zoltán Vokó, Krisztina Bogos,
Objective Hungary has repeatedly been shown to have the highest cancer-related mortality and incidence in Europe. Despite lung cancer being the most abundant malignant diagnosis in Hungary, numerous concerns have been raised recently regarding the bias inherent to reported incidence estimates. Re-analysis of reimbursement claims has been suggested previously by our group as an alternative approach, offering revised figures of lung cancer incidence between 2011 and 2016. Leveraging on this methodology, ...
Tópico(s): Colorectal Cancer Screening and Detection
2024 - Springer Science+Business Media | Pathology & Oncology Research
Jeffrey Laurence, Michael Franklin,
... Jeffrey B. Rubins Harold Hilton Sandstead George A. Sarosi Gregory Stephen Sayuk Matthias Schaier Alvin H. Schmaier ...
2007 - Elsevier BV | Translational research